People · Operator
Named in public records as an officer, director or promoter · active 2019–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Excision BioTherapeutics Inc | — | Biotechnology | Series C | $71.2M | $338.5M | 2021 |
| Outpace Bio, Inc. | — | Biotechnology | Series C | $56.0M | $491.3M | 2024 |
| Unnatural Products Inc. | — | Biotechnology | Series B | $30.1M | $269.8M | 2019 |
| OverT Bio, Inc. | — | Biotechnology | Series B | $16.0M | $194.5M | 2023 |
| Halcyon Wellness Inc. | — | Biotechnology | Series A | $8.0M | $18.9M | 2026 |
Vasudev Bailey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vasudev Bailey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ashok Krishnamurthi | 1 | 8 |
| Jake Simson | 1 | 6 |
| Sara Choi | 1 | 5 |
| Bahija Jallal | 1 | 3 |
| Prem Tumkosit | 1 | 2 |
| William Carson | 1 | 2 |
| Alic Chen | 1 | 2 |
| Neville Sanjana | 1 | 1 |
| Joshua Schwochert | 1 | 1 |
| Cameron Pye | 1 | 1 |
| Daniel Dornbusch | 1 | 1 |
| Aaron Foster | 1 | 1 |
| Charity Scripture | 1 | 1 |
| Scott Boyken | 1 | 1 |
| Eric Soller | 1 | 1 |
| Marc Lajoie | 1 | 1 |
| Mateusz Legut | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.